Oruka Therapeutics Inc
NASDAQ:ORKA

Watchlist Manager
Oruka Therapeutics Inc Logo
Oruka Therapeutics Inc
NASDAQ:ORKA
Watchlist
Price: 30.79 USD -2.1%
Market Cap: 1.5B USD

Intrinsic Value

The intrinsic value of one ORKA stock under the Base Case scenario is 10.35 USD. Compared to the current market price of 30.79 USD, Oruka Therapeutics Inc is Overvalued by 66%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ORKA Intrinsic Value
10.35 USD
Overvaluation 66%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Oruka Therapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about ORKA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ORKA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Oruka Therapeutics Inc.

Explain Valuation
Compare ORKA to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Contacts
Loading...
How do you feel about ORKA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Oruka Therapeutics Inc

Current Assets 355.2m
Cash & Short-Term Investments 349.2m
Other Current Assets 6m
Non-Current Assets 154.1m
Long-Term Investments 151.8m
PP&E 2.2m
Other Non-Current Assets 103k
Current Liabilities 21m
Accounts Payable 2.2m
Accrued Liabilities 9.1m
Other Current Liabilities 9.7m
Non-Current Liabilities 1.5m
Other Non-Current Liabilities 1.5m
Efficiency

Free Cash Flow Analysis
Oruka Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Oruka Therapeutics Inc

Revenue
0 USD
Operating Expenses
-117.9m USD
Operating Income
-117.9m USD
Other Expenses
16.3m USD
Net Income
-101.6m USD
Fundamental Scores

ORKA Profitability Score
Profitability Due Diligence

Oruka Therapeutics Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
ROE is Increasing
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
29/100
Profitability
Score

Oruka Therapeutics Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

ORKA Solvency Score
Solvency Due Diligence

Oruka Therapeutics Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Oruka Therapeutics Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ORKA Price Targets Summary
Oruka Therapeutics Inc

Wall Street analysts forecast ORKA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ORKA is 47.75 USD with a low forecast of 26.26 USD and a high forecast of 66.15 USD.

Lowest
Price Target
26.26 USD
15% Downside
Average
Price Target
47.75 USD
55% Upside
Highest
Price Target
66.15 USD
115% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for ORKA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ORKA Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ORKA stock?

The intrinsic value of one ORKA stock under the Base Case scenario is 10.35 USD.

Is ORKA stock undervalued or overvalued?

Compared to the current market price of 30.79 USD, Oruka Therapeutics Inc is Overvalued by 66%.

Back to Top